DFTX FY 2016 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

FY 2016 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$111,250

Net Income

-$179,900

EPS (Diluted)

$-2.24

Cash Flow

Operating Cash Flow

-$26,636

Free Cash Flow

-$56,734

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$202,750

Total Liabilities

$75,471

Stockholders' Equity

$127,279

Cash & Equivalents

$10,962

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$111,250	-$94,550	-17.7%
Net Income	-$179,900	-$92,656	-94.2%